抗反流黏膜切除术与腹腔镜Nissen胃底折叠术的围术期及生活质量对比
一项回顾性匹配队列研究比较了抗反流黏膜切除术(ARMS,n=33)与腹腔镜Nissen胃底折叠术(NF,n=67)的围术期及生活质量结局。ARMS组围术期指标更优,但30.3%需追加腹腔镜抗反流手术;两组在GERD-HRQL、RSI及吞咽困难评分上至术后2年无差异,ARMS组腹胀症状更少。
要点
- ARMS围术期恢复优于NF,但约30%患者需追加腹腔镜抗反流手术。
- 两组术后2年内反流生活质量评分无显著差异。
- ARMS组术后腹胀症状更少,吞咽困难在3周时增加但6个月后消退。
核心结论
- ARMS围术期结局优于NF,反流生活质量结局与NF相当。
- ARMS可作为合适选择的GERD患者的有效内镜干预,且不限制未来腹腔镜抗反流手术。
研究设计与样本
- 回顾性综述前瞻性维护的质量数据库,ARMS组33例与NF组67例进行匹配。
- 收集术前及术后至2年的临床和生活质量结局,采用RSI、GERD-HRQL和吞咽困难评分。
- 使用Wilcoxon秩和检验和Fisher精确检验比较结局。
主要发现
- ARMS组10例(30.3%)需追加腹腔镜抗反流手术。
- ARMS组手术时间更短(p<0.001)、估计失血量更少(p<0.001)、住院时间更短(p<0.001)。
- ARMS组出院时疼痛更轻(p=0.007)、更早停用麻醉药(p<0.001)、更早恢复日常生活活动(p<0.001)。
- 两组30天并发症率、急诊就诊率或再入院率无差异。
- ARMS组术后各时间点腹胀症状更少(所有p<0.05);两组术后3周吞咽困难均增加(p<0.01),但6个月、1年、2年时未持续。
关键数值与推荐
- ARMS组追加腹腔镜抗反流手术比例为30.3%(10/33)。
- 两组在术后3周、6个月、1年、2年的GERD-HRQL、RSI或吞咽困难评分无差异。
- ARMS组腹胀症状在术后所有时间点均少于NF组(所有p<0.05)。
临床怎么用
- 对于合适选择的GERD患者,ARMS可提供与NF相当的反流生活质量改善,且围术期恢复更优。
- ARMS术后部分患者可能需追加腹腔镜抗反流手术,应告知患者并做好预案。
局限性
- 回顾性研究设计,样本量较小(ARMS组33例,NF组67例)。
- 非随机分组,可能存在选择偏倚。
- 随访时间限于术后2年。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anti-reflux mucosectomy (ARMS) is a new endoscopic procedure involving a hemi-circumferential endoscopic mucosal resection (EMR) around the gastroesophageal junction. We aim to compare perioperative and quality of life outcomes of patients with reflux who underwent ARMS to a comparable group who underwent laparoscopic Nissen fundoplication (NF). METHODS: A retrospective review of a prospectively maintained quality database was performed. All patients who underwent ARMS (n = 33) were matched with patients who underwent NF (n = 67). Clinical and quality of life (QOL) outcomes were collected preoperatively and up to two years postoperatively, measured by the Reflux Symptom Index (RSI), Gastroesophageal Reflux Disease-Health Related Quality of Life (GERD-HRQL), and Dysphagia Score. Outcomes were compared using the Wilcoxon rank-sum and Fisher's exact test. RESULTS: While 10 patients (30.3%) who underwent ARMS required additional laparoscopic anti-reflux operations, the ARMS group had shorter OR time (p<0.001), less estimated blood loss (p<0.001), shorter hospital stay (p<0.001), less pain at discharge (p = 0.007), earlier narcotic discontinuation (p<0.001), and earlier return to activities of daily living (p<0.001) compared to the NF group. There was no difference in 30-day complication rates, emergency room visits, or readmission rates between the groups. There was no difference between ARMS and NF groups in terms of GERD-HRQL, RSI, or Dysphagia scores at 3 weeks, 6 months, 1 year, or 2 years postoperatively. However, the ARMS group reported less symptoms of gas and bloating postoperatively at all time points (all p<0.05). Both groups reported increased dysphagia at 3 weeks postoperatively (p<0.01) but this did not persist at 6 months, 1 year, or 2 years. CONCLUSION: While ARMS had better perioperative outcomes compared to NF, reflux quality of life outcomes were comparable. ARMS can be an effective endoscopic intervention for GERD when performed on appropriately selected patients without limiting future laparoscopic anti-reflux interventions.
引用
- Wong HJ, Su B, Attaar M, et al. Anti-reflux mucosectomy (ARMS) results in improved recovery and similar reflux quality of life outcomes compared to laparoscopic Nissen fundoplication. Surg Endosc. 2020. PMID: 33237465. doi:10.1007/s00464-020-08144-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。